Purchase Order 75N91023P00773
Award Date 8/25/23
Potential Completion Date 9/25/23
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for $19,000 on July 27, 2019, with completion on July 26, 2020. Performance takes place in Bethesda, Maryland. The order is for firm fixed price commercial items typical of Nanostring's product line—genomic analysis platforms, reagents, assays, or related laboratory consumables supporting molecular and translational research.</p>
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $25,000 purchase order to Nanostring Technologies, Inc. for testing services. The firm fixed price contract will be performed in Seattle, Washington over a four month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's biomedical research mission. No subcontractors or set aside designations...
- <p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for $24,150.00 on September 3, 2020, with an ultimate completion date of October 2, 2020. The order covers biological kits on a firm fixed price basis. Work is performed in Seattle, Washington. No set-aside category applies to this award.</p>
- The National Cancer Institute awarded Nanostring Technologies, Inc. a $5,974.50 firm fixed price call against a blanket purchase agreement for biological materials, chemicals, and laboratory supplies on April 17, 2018. The contract, which was not set aside for small businesses, represents a delivery order for specialized genomic analysis consumables and reagents to support the National Cancer Institute's research initiatives. The work was completed by May 17, 2018, with performance taking...
- <p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for biological kits valued at $22,160.00 on April 8, 2021, with ultimate completion on May 7, 2021. Place of performance is Seattle, Washington. The order is for specialized laboratory reagents and consumables to support genomic and molecular analysis research.</p>
- <p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. valued at $22,388.00 for drugs and biologicals, effective September 16, 2020, with completion by October 31, 2020. Place of performance is Seattle, Washington. The order is firm fixed price with no small business set-aside.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order to Nanostring Technologies, Inc., a publicly held provider of life science tools, for HU V3 MIRNA REAGENTS. The contract has a potential value of $24,339.90 and a completion date of September 5, 2023. Nanostring Technologies has an extensive history of providing specialized laboratory equipment, consumables, and testing services to support genomic,...
- The National Cancer Institute awarded a $21.44K firm fixed price BPA (Blanket Purchase Agreement) call to Nanostring Technologies, Inc. on March 15, 2024, for nanoString CosMx reagents, with an ultimate completion date of April 14, 2024. This contract represents a delivery order under an existing blanket purchase agreement vehicle and requires no set-aside designation. Nanostring Technologies, a publicly traded provider of advanced genomic analysis platforms and life science tools, will supply...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm-fixed-price purchase order to Nanostring Technologies, Inc., a for-profit manufacturer of life science tools, for the provision of NanoString GeoMX Digital Spatial Profiling and nCounter MAX System equipment and services to support the Laboratory of Pathology's Single-Cell RNA Facility. The $496,250 contract has a completion date of September 3, 2020 and does not utilize a...
- <p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for biological kits valued at $23,204.00, with an award date of May 18, 2021 and ultimate completion date of June 17, 2021. Place of performance is Seattle, Washington. The order is priced on a firm fixed price basis with no set-aside designation.</p>